{"filing":{"accession_number":"0001493152-26-038072","cik":"0001624326","ticker":"PAVM","company_name":"PAVmed Inc.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315226038072/form8-k.htm"},"events":[{"id":27808,"run_id":25379,"accession_number":"0001493152-26-038072","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"PAVmed issued a press release on August 14, 2026, announcing financial results for the fiscal quarter ended June 30, 2026, including operating expenses of $7.1 million, GAAP net loss of $5.5 million ($(0.87) per share), and cash position of $3.8 million as of June 30, 2026. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.","company_name":"PAVmed Inc.","ticker":"PAVM","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29493,"accession_number":"0001493152-26-038072","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"PAVmed issued a press release on August 14, 2026, announcing financial results for the fiscal quarter ended June 30, 2026, including operating expenses of $7.1 million, GAAP net loss of $5.5 million ($(0.87) per share), and cash position of $3.8 million as of June 30, 2026. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T14:45:49.098216+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29493,"accession_number":"0001493152-26-038072","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"PAVmed issued a press release on August 14, 2026, announcing financial results for the fiscal quarter ended June 30, 2026, including operating expenses of $7.1 million, GAAP net loss of $5.5 million ($(0.87) per share), and cash position of $3.8 million as of June 30, 2026. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T14:45:49.098216+00:00","company_name":"PAVmed Inc.","ticker":"PAVM","filing_date":"2026-08-14"}]}